reviewPharmacological ReviewsSep 1, 2006Closed access

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

AKAnatol KontushMJM. John Chapman

Hôpital Broussais

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

731
total citations
FWCI
17.65
Percentile
100%
References
479
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Chemistry
  • Cholesterylester transfer protein
  • Cholesterol
  • Lipoprotein
  • High-density lipoprotein
  • Apolipoprotein B
  • Internal medicine
  • Inflammation
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.